Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination
- 3 April 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 84 (1) , 27-49
- https://doi.org/10.1189/jlb.0907649
Abstract
As is the case in other viral infections, humans respond to HIV infection by activating their NK cells. However, the virus uses several strategies to neutralize and evade the host’s NK cell responses. Consequently, it is not surprising that NK cell functions become compromised in HIV-infected individuals in early stages of the infection. The compromised NK cell functions also adversely affect several aspects of the host’s antiviral adaptive immune responses. Researchers have made significant progress in understanding how HIV counters NK cell responses of the host. This knowledge has opened new avenues for immunotherapy and vaccination against this infection. In the first part of this review article, we gave an overview of our current knowledge of NK cell biology and discussed how the genes encoding NK cell receptors and their ligands determine innate genetic resistance/susceptibilty of humans against HIV infections and AIDS. In this second part, we discuss NK cell responses, viral strategies to counter these responses, and finally, their implications for anti-HIV immunotherapy and vaccination.Keywords
Funding Information
- Research Center for insightful discussions
- Canadian Institutes of Health Research
- FRSQ
This publication has 270 references indexed in Scilit:
- Interleukin 15–mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1Nature Immunology, 2007
- Lenatural killer, fer de lance des futures immunothérapies anti-tumorales ?médecine/sciences, 2007
- HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1Proceedings of the National Academy of Sciences, 2007
- Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infectionThe Journal of Experimental Medicine, 2006
- Release of MICB Molecules by Tumor Cells: Mechanism and Soluble MICB in Sera of Cancer PatientsHuman Immunology, 2006
- Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodiesCancer and Metastasis Reviews, 2005
- HIV‐1 Tat Triggers TGF‐β Production and NK Cell Apoptosis that is Prevented by Pertussis Toxin BClinical and Developmental Immunology, 2000
- Activation-induced NK cell death triggered by CD2 stimulationEuropean Journal of Immunology, 1998
- The Th1/Th2 paradigmImmunology Today, 1997
- Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infectionCytometry, 1995